Neurocysticercosis

• FDA approval · 2024-09-04
  FDA Approved: ALBENDAZOLE — Original Application (Alembic Pharmaceuticals Inc.)

  FDA approves Alembic Pharmaceuticals' original application for albendazole, adding a generic version to the market.

• FDA approval · 2023-12-19
  FDA Approved: BILTRICIDE — Supplemental Application (Bayer HealthCare Pharmaceuticals Inc.)

  FDA approved a supplemental application for Biltricide (praziquantel) to update the label with expanded indications for treating helminth in…

• FDA approval · 2021-01-26
  FDA Approved: ALBENDAZOLE — Original Application (Dr.Reddys Laboratories Inc)

  FDA has approved Dr. Reddy's Laboratories Inc for albendazole under an Original Application, confirming the generic's authorization for list…

• FDA approval · 2021-01-22
  FDA Approved: ALBENDAZOLE — Original Application (Novadoz Pharmaceuticals LLC)

  FDA approved the original application for albendazole from Novadoz Pharmaceuticals LLC.

• FDA approval · 2019-05-14
  FDA Approved: ALBENDAZOLE — Original Application (Edenbridge Pharmaceuticals LLC.)

  FDA approved Edenbridge Pharmaceuticals' generic Albendazole as an Original Application under ANDA211117, making a generic version of albend…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• FDA approval · 2017-11-27
  FDA Approved: PRAZIQUANTEL — Original Application (Endo USA, Inc.)

  The FDA approved Endo USA, Inc.'s original application for praziquantel, enabling a generic version of the antihelminthic.

• FDA approval · 2014-11-20
  FDA Approved: BILTRICIDE — Supplemental Application (Bayer HealthCare Pharmaceuticals Inc.)

  FDA approved a supplemental application for Biltricide (praziquantel) from Bayer HealthCare Pharmaceuticals Inc., authorizing changes to the…

• FDA approval · 2009-10-20
  FDA Approved: ALBENDAZOLE — Supplemental Application (Amneal Pharmaceuticals of New York LLC)

  FDA approved a supplemental application for Albendazole submitted by Amneal Pharmaceuticals of New York LLC.